Innovex (INVX) Q2 2026 Earnings Call Transcript

Innovex reported Q2 2026 revenue of $245M (+9% YoY, +2% sequentially) and adjusted EBITDA of $48M (20% margin), both at the high end of guidance, with free cash flow of $30M (63% conversion of adjusted EBITDA). The company completed its $95M TCO Group acquisition on July 1 (paid $65M cash and $30M stock) and guided Q3 revenue to $260M–$270M and adjusted EBITDA to $51M–$57M, reflecting a full-quarter TCO contribution (~$15M revenue and ~$3M EBITDA). Management also reported a cash balance of ~$222M with no bank debt, expects capital expenditures at ~2.7% of revenue, and used $14.1M to repurchase shares at an average $24.59/share.

Analysis

INVX looks like a self-help compounder with a real second-order margin tailwind, not just a cyclical beta trade. The important mechanism is that the company is increasingly monetizing a wider installed base through consumables and niche downhole products, so incremental offshore and international volume should convert at a much higher rate than the headline revenue growth suggests. That makes the main winners the stock itself and, indirectly, equipment-light competitors that can also monetize technical complexity; the losers are more commoditized service providers that depend on price rather than qualification barriers.

The near-term setup is less about Q3 revenue and more about whether management can keep expanding EBITDA margin while the Middle East freight drag fades. If that logistics headwind persists or project timing slips, the market could conclude the recent strength is just acquisition optics. The real catalyst path is 1-3 months: Q3 print, TCO integration proof, and evidence that Mexico/U.S. land and offshore awards are converting into backlog. The structural story is 6-18 months, where Brazil/Norway/UAE cross-sell and Asia project revenue can re-rate the multiple if execution stays clean.

Consensus may be underestimating how much of the upside is already embedded in operating leverage rather than M&A. The contrarian risk is that investors extrapolate the new phase too quickly before the 2027 offshore pipeline and TCO synergies are visible in reported numbers. Falsifiers: sub-20% EBITDA margin for another quarter, weaker-than-guided Q3 EBITDA, or no follow-through on award conversion by year-end.

Key Decisions for Investors

• Long INVX common on pullbacks over the next 1-3 weeks; thesis is margin expansion plus higher-quality mix, with a 6-18 month re-rate if EBITDA margins hold above 20% and TCO starts contributing more than modeled.
• Pair trade: long INVX / short OIH for 1-3 months to isolate idiosyncratic execution versus broader oilfield-services beta; this works if offshore awards and cross-sell drive upside while sector multiples remain rangebound.
• If entering ahead of Q3, keep size modest and use a hard stop if Q3 EBITDA lands below the guided midpoint or if management flags ongoing Middle East logistics drag beyond Q4.
• Watchlist alert rather than immediate trade: add on confirmation that TCO runs above the implied $3M Q3 EBITDA run-rate and that Q4 guidance steps up; that would validate the synergy story without needing macro help.